These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 15780904)
1. Chemoprevention of prostate cancer. Klein EA Crit Rev Oncol Hematol; 2005 Apr; 54(1):1-10. PubMed ID: 15780904 [TBL] [Abstract][Full Text] [Related]
2. Update on prostate cancer chemoprevention. Lowe JF; Frazee LA Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer chemoprevention: current status and future prospects. Gupta S Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645 [TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of prostate cancer: agents and study designs. Thompson IM J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117 [TBL] [Abstract][Full Text] [Related]
5. Can prostate cancer be prevented? Klein EA Nat Clin Pract Urol; 2005 Jan; 2(1):24-31. PubMed ID: 16474573 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of prostate cancer. Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Klein EA J Urol; 2009 Aug; 182(2):499-507; discussion 508. PubMed ID: 19524966 [TBL] [Abstract][Full Text] [Related]
7. [Chemoprevention of prostate cancer]. Xie LP; Qin J Zhonghua Nan Ke Xue; 2005 Apr; 11(4):243-6. PubMed ID: 15921250 [TBL] [Abstract][Full Text] [Related]
8. An update on chemoprevention strategies in prostate cancer for 2006. Neill MG; Fleshner NE Curr Opin Urol; 2006 May; 16(3):132-7. PubMed ID: 16679848 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of prostate cancer. Stephenson AJ; Abouassaly R; Klein EA Urol Clin North Am; 2010 Feb; 37(1):11-21, Table of Contents. PubMed ID: 20152515 [TBL] [Abstract][Full Text] [Related]
10. [Nutrition and pharmacological treatment for prevention of prostate cancer]. Segev Y; Nativ O Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727 [TBL] [Abstract][Full Text] [Related]
11. Lycopene in the prevention of prostate cancer. Dahan K; Fennal M; Kumar NB J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908 [TBL] [Abstract][Full Text] [Related]
12. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Lippman SM; Lee JJ Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634 [TBL] [Abstract][Full Text] [Related]
13. Androgens and prevention of prostate cancer. Sarvis JA; Thompson IM Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):271-7. PubMed ID: 18438176 [TBL] [Abstract][Full Text] [Related]
14. Phase III prostate cancer prevention trials: are the costs justified? Thompson IM; Tangen CM; Klein EA; Lippman SM J Clin Oncol; 2005 Nov; 23(32):8161-4. PubMed ID: 16278467 [TBL] [Abstract][Full Text] [Related]
16. Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial. Crawford ED; Andriole GL; Marberger M; Rittmaster RS Urology; 2010 Mar; 75(3):502-9. PubMed ID: 20035983 [TBL] [Abstract][Full Text] [Related]
17. Update on chemoprevention of prostate cancer. Klein EA; Thompson IM Curr Opin Urol; 2004 May; 14(3):143-9. PubMed ID: 15069304 [TBL] [Abstract][Full Text] [Related]